494
2. Carvalho-AssefAP, Pereira PS, AlbanoRM,et al. Isolation ofNDM-producing Providencia rettgeri in Brazil. J Antimicrob Chemother 2013;68:2956–2957.
3. Rozales FP, MagagninCM,CamposJC, et al. Characterization of transform- ants obtained from NDM-1-producing Enterobacteriaceae in Brazil. Infect Control Hosp Epidemiol 2017;38:634–636.
4. Aires CA, Pereira PS, de Araujo CF, et al. Multiclonal expansion of Klebsiella pneumoniae isolates producing NDM-1 in Rio de Janeiro, Brazil. Antimicrob Agent Chemother 2017;61:e01048–16.
5. CampanaEH,Montezzi LF,PaschoalRP, PicãoRC.NDM-producingKlebsiella pneumoniae ST11 goes to the beach. Int J Antimicrob Agent 2017;49:119–121.
6. Monteiro J, Widen RH, Pignatari AC, Kubasek C, Silbert S. Rapid detection of carbapenemase genes by multiplex real-time PCR. J Antimicrob Chemother 2012;67:906–909.
Otávio Hallal Ferreira Raro et al
7. Castanheira M, Costello AJ, Deshpande LM, Jones RN. Expansion of clonal complex 258 KPC-2–producing Klebsiella pneumoniae in Latin American hospitals: report of the SENTRY Antimicrobial Surveillance Program. Antimicrob Agent Chemother 2012;56:1668–1669.
8. Eibach D, Dekker D, Gyau Boahen K, et al. Extended-spectrum beta-lacta- mase-producing Escherichia coli and Klebsiella pneumoniae in local and imported poultry meat in Ghana. Vet Microbiol 2018;217:7–12.
9. Nordmann P, Poirel L, Walsh TR, Livermore DM. The emergingNDMcar- bapenemases. Trends Microbiol 2011;19:588–595.
10. Walsh TR, Weeks J, Livermore DM,Toleman MA. Dissemination ofNDM- 1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study. Lancet Infect Dis 2011;11:355–362.
Putative horizontal transfer of carbapenem resistance between Klebsiella pneumoniae and Kluyvera ascorbata during abdominal infection: A case report
Otávio Hallal Ferreira Raro MSc1 , Daiana de Lima-Morales PhD2, Afonso Luis Barth PhD2, Tiago Galvão Paim PhD3, Mariana Preussler Mott MSc1, Cezar Vinícius Würdig Riche MSc1, Uirá Fernandes Teixeira PhD4, Fábio Luiz Waechter PhD4
and Cícero Armídio Gomes Dias PhD1 1Departamento de Ciências da saúde da Universidade Federal de Ciências da Saúde de Porto Alegre - UFCSPA, Porto Alegre, Rio Grande do Sul, Brazil, 2LABRESIS - Laborat´
— orio de Pesquisa em Resistência Bacteriana, Hospital de Clínicas de Porto Alegre, Porto Alegre, Rio Grande do Sul, Brazil, 3Instituto de
Biociências da Universidade Federal do Rio Grande do Sul – UFRGS, Porto Alegre, Rio Grande do Sul, Brazil, Brazil and 4Serviço de Cirurgia do Aparelho Digestivo da UFCSPA/Santa Casa – UFCSPA, Porto Alegre, Rio Grande do Sul, Brazil
To the Editor The emergence of KPC-producing Enterobacter has
led to the development of serious infections related to high levels of mortality and morbidity worldwide.1,2 The rapid spread of KPCs is linked to multiple elements, such as plasmid-borne genes and the dissemination by international travelers; these bacteria are frequently multidrug resistant, causing untreatable infections.3,4 Kluyvera spp is a genus of gram-negative rods of the Enterobacteriaceae family.5 Although it is a commensal of the human gut microbiota,6 Kluyvera spp has the potential to cause septic shock, urinary tract infections, catheter-associated bloodstream infections, and abdomi- nal infections.7 Here, we report a case of a plasmid-mediated hori- zontal transfer from a Klebsiella pneumoniae isolate to a Kluyvera ascorbata isolate during abdominal infection. The patient approved the data submission. A43-year-oldmale patientwas admitted to theHepatobiliary and
Pancreatic Surgical Division from a hospital in the South Region of Brazil in October 2016. He was asymptomatic but had an incidental type 1 biliary cyst that was discovered during ultrasonography. Magnetic resonance imaging (MRI) with cholangiopancreatography was performed for adequate evaluation and showed an abnormal pancreatobiliary junction, as well. In November 2016, the patient underwent a cholecystectomy and total resection of the cyst, with closure of distal part of the main bile duct inside the pancreas, accompanied by Roux-en-Y hepaticojejunostomy to provide proper
Author for correspondence: Otávio Hallal Ferreira Raro, E-mail: otaviohraro@gmail. com Cite this article: Raro OHF, et al. (2019). Putative horizontal transfer of carbapenem
resistance between Klebsiella pneumoniae and Kluyvera ascorbata during abdominal infection: A case report. Infection Control & Hospital Epidemiology, 40: 494–496, https://
doi.org/10.1017/ice.2019.26
© 2019 by The Society for Healthcare Epidemiology of America. All rights reserved.
biliary drainage. The pathology report showed no malignancy in surgical specimen. After 48 hours, the patient was evaluated with postoperative pancreatitis and signs of sepsis, therefore piperacillin/ tazobactam treatment was started. The patient continued to present clinical deterioration and needed parenteral nutrition; he was conse- quently transferred to the intensive care unit (ICU). Blood cultures were negative and abdominal computerized tomography (CT) showed abdominal collections. CT-guided drainage of pancreatic fluid was performed and cultures were negative. Nevertheless, anti- microbial treatment with meropenem was started and continued for 14 days without resolution. A second CT-guided drainage procedure was performed at the end of December, and the bacte- riological culture yielded a multisusceptible Enterococcus faecalis; a Kluyvera ascorbata resistant to ampicillin and second-generation cephalosporin but susceptible to carbapenem, and multidrug- resistant Klebsiella pneumoniae, including resistance to tigecycline and carbapenem. Antibiotics were adjusted to vancomycin, mero- penem, and ertapenemplus polymyxinBwith clinical improvement but without complete bacterial clearance. After 17 days, a third CT-guided drainage was performed, and the bacterial culture yielded 1 K. ascorbata isolate resistant to carbapenem. A fourth CT-guided drainage was performed after 15 days, and the culture yielded K. ascorbata susceptible to carbapenem and K. pneumoniae resistant to carbapenem. Antibiotic treatment was adjusted to polymyxin B, tigecycline, and sulfametoxazol-trimetoprim, and the patient was evaluated with signs of controlled infection. After 14 days, the antibiotic treatment was suspended, and a final CT showed no signs of abdominal collections. The patient was dis- charged and was followed as an outpatient.
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112 |
Page 113 |
Page 114 |
Page 115 |
Page 116 |
Page 117 |
Page 118 |
Page 119 |
Page 120 |
Page 121 |
Page 122